About me...
Striking Achievements
- The epidemiology of polypharmacy in older adults: register-based prospective cohort study, Clin Epidemiol. 2018 Mar 12;10:289-298
- Polypharmacy, potentially inappropriate medications and drug-drug interactions in geriatric patients with hematologic malignancy: Observational single-center study of 122 patients, J Geriatr Oncol. 2018 Jan;9(1):60-67
- Polypharmacy in multimorbid older adults: protocol for a systematic review, Syst Rev. 2017 May 19;6(1):104
- Towards therapeutic drug monitoring of everolimus in cancer? Results of an exploratory study of exposure-effect relationship, Pharmacol Res. 2017 Jul;121:138-144
- Prevalence of Potentially Inappropriate Medication Use in Older Adults Living in Nursing Homes: A Systematic Review, J Am Med Dir Assoc. 2016 Sep 1;17(9):862.e1-9
- 2013-nowadays Associate professor of Clinical Pharmacology, Faculty of Medicine, University of Limoges, France
- 2009-nowadays Hospital practitioner, Pharmacology, Toxicology and Pharmacovigilance Department, University Hospital of Limoges, France
- 2011 Postdoc at Chair on treatment adherence, URESP, Laval University, Quebec, Canada
- 2009-2013 Assistant professor of Clinical Pharmacology, Faculty of Medicine, University of Limoges, France
- 2004-2007 PhD at the University of Limoges (Faculty of Medicine) Limoges (France)
- 2004-2008 Hospital practitioner junior, Pharmacology, Toxicology and Pharmacovigilance Department, University Hospital of Limoges, France
- 2004-2008 Clinical Head Assistant, Faculty of Medicine, University of Limoges, France
- 2004 Licentiate in public health sciences; University of Limoges, France
- 2004 MD at the Faculty of Medicine – Limoges (France)
- 2000-2004 Intern of University Hospital of Limoges and Bordeaux, France
- Prix Réné Cassaing (2008)
- Collaborative Network
- Member of SIGE Elderly of ISPE
- Member of Quebec Research Network on Medications
- Collaboration with Centre for Excellence in Aging of University Laval (Quebec, Canada),
- Karolinska Institute (Stockholm, Sweden),
- Pharmacy Faculty (Bruxelles, Belgium),
- Hospital University of Lausanne (Swiss),
- Sydney University (Australia)
- Supervision
- Faculty of medicine and pharmacy -Limoges (France): 1st, 2nd and 3rd cycle
- Paramedical schools (nurses, midwifes, etc.)
- Master Pharmacoepidemiology and Pharmacovigilance academic degree
- PharmD or MD academic degree
- PhD Pharmacoepidemiology academic degree
- Teaching Experiences (students in Biology & Pharmacy):
- Clinical pharmacology, pharmacovigilance and pharmacoepidemiology
- 2013-nowadays Head of Regional Centre of Pharmacovigilance, Pharmacoepidemiology and Drug Information, Limoges, France
RESEARCH ACTIVITIES
Marie-Laure Laroche is professor of Clinical Pharmacology at the Limoges Faculty of Medicine (France). She is the head the Pharmacovigilance and Pharmacoepidemiology Centre setting up on the Limoges’s University Hospital. His Centre is part of the 31 French Pharmacovigilance Centre network, contributing to the collect of adverse drug reactions and the information on medicine use for health professionals. She sits on the French Medicine Agency (ANSM) and contributes to the assessment of medicine safety and to the taking final decision. Her daily clinical activity in pharmacovigilance allows comprehending factors associated to adverse drug reactions in various populations. As a researcher of the Limoges University, she investigates how to optimize medication use in older people. She developed the French list of potentially inappropriate medications (PIM). Currently, she is working on the exposure to PIM among older people in the last months of life (collaboration with Aging Research Centre of Karolinska Institute-Sweden). Since 2014, she has collaborated with the Quebec Centre for Excellence in Aging and INSPQ about polypharmacy in seniors. Since 2017, she is working on deprecription in older adults and caregivers with Australia, Canada, Belgium and Swiss.
